TY  - GEN
AU  - Ciuleanu,Tudor
AU  - Socinski,Mark A
AU  - Obasaju,Coleman
AU  - Luft,Alexander V
AU  - Szczesna,Aleksandra
AU  - Szafrański,Wojciech
AU  - Ramlau,Rodryg
AU  - Bálint,Beatrix
AU  - Molinier,Olivier
AU  - Depenbrock,Henrik
AU  - Nanda,Shivani
AU  - Paz-Ares,Luis
AU  - Thatcher,Nick
TI  - Efficacy and Safety of Necitumumab Continuation Therapy in the Phase III SQUIRE Study of Patients With Stage IV Squamous Non-Small-Cell Lung Cancer
SN  - 1938-0690
PY  - 2019///0408
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antibodies, Monoclonal
KW  - therapeutic use
KW  - Antibodies, Monoclonal, Humanized
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Carcinoma, Squamous Cell
KW  - drug therapy
KW  - Cisplatin
KW  - Deoxycytidine
KW  - analogs & derivatives
KW  - ErbB Receptors
KW  - immunology
KW  - Female
KW  - Humans
KW  - Immunotherapy
KW  - methods
KW  - Lung Neoplasms
KW  - Male
KW  - Middle Aged
KW  - Neoplasm Staging
KW  - Survival Analysis
KW  - Gemcitabine
N1  - Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.cllc.2017.10.004
ER  -